| pubmed-article:15521105 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15521105 | lifeskim:mentions | umls-concept:C0027651 | lld:lifeskim |
| pubmed-article:15521105 | lifeskim:mentions | umls-concept:C0026882 | lld:lifeskim |
| pubmed-article:15521105 | lifeskim:mentions | umls-concept:C0008667 | lld:lifeskim |
| pubmed-article:15521105 | lifeskim:mentions | umls-concept:C0205422 | lld:lifeskim |
| pubmed-article:15521105 | lifeskim:mentions | umls-concept:C1442161 | lld:lifeskim |
| pubmed-article:15521105 | lifeskim:mentions | umls-concept:C0004083 | lld:lifeskim |
| pubmed-article:15521105 | lifeskim:mentions | umls-concept:C1521733 | lld:lifeskim |
| pubmed-article:15521105 | lifeskim:mentions | umls-concept:C0439828 | lld:lifeskim |
| pubmed-article:15521105 | pubmed:issue | 5A | lld:pubmed |
| pubmed-article:15521105 | pubmed:dateCreated | 2004-11-2 | lld:pubmed |
| pubmed-article:15521105 | pubmed:abstractText | Chromosomal aberrations in breast tumors from BRCA1 and BRCA2 germ-line mutation carriers are considerably more frequent than what is seen in sporadic breast tumors. According to Comparative Genomic Hybridisation analysis (CGH), deletions on chromosome 4 are one of the most frequent events in BRCA1-associated tumors, suggesting inactivation of specific tumor suppressor genes. | lld:pubmed |
| pubmed-article:15521105 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15521105 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15521105 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15521105 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15521105 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15521105 | pubmed:issn | 0250-7005 | lld:pubmed |
| pubmed-article:15521105 | pubmed:author | pubmed-author:BorgAkeA | lld:pubmed |
| pubmed-article:15521105 | pubmed:author | pubmed-author:AgnarssonBjar... | lld:pubmed |
| pubmed-article:15521105 | pubmed:author | pubmed-author:HeikkiläPäivi... | lld:pubmed |
| pubmed-article:15521105 | pubmed:author | pubmed-author:ArasonAdalgei... | lld:pubmed |
| pubmed-article:15521105 | pubmed:author | pubmed-author:NevanlinnaHel... | lld:pubmed |
| pubmed-article:15521105 | pubmed:author | pubmed-author:BarkardottirR... | lld:pubmed |
| pubmed-article:15521105 | pubmed:author | pubmed-author:EgilssonValga... | lld:pubmed |
| pubmed-article:15521105 | pubmed:author | pubmed-author:EerolaHannale... | lld:pubmed |
| pubmed-article:15521105 | pubmed:author | pubmed-author:OlssonHakanH | lld:pubmed |
| pubmed-article:15521105 | pubmed:author | pubmed-author:Johannsdottir... | lld:pubmed |
| pubmed-article:15521105 | pubmed:author | pubmed-author:Johannesdotti... | lld:pubmed |
| pubmed-article:15521105 | pubmed:author | pubmed-author:JohannssonOsk... | lld:pubmed |
| pubmed-article:15521105 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15521105 | pubmed:volume | 24 | lld:pubmed |
| pubmed-article:15521105 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15521105 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15521105 | pubmed:pagination | 2681-7 | lld:pubmed |
| pubmed-article:15521105 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15521105 | pubmed:meshHeading | pubmed-meshheading:15521105... | lld:pubmed |
| pubmed-article:15521105 | pubmed:meshHeading | pubmed-meshheading:15521105... | lld:pubmed |
| pubmed-article:15521105 | pubmed:meshHeading | pubmed-meshheading:15521105... | lld:pubmed |
| pubmed-article:15521105 | pubmed:meshHeading | pubmed-meshheading:15521105... | lld:pubmed |
| pubmed-article:15521105 | pubmed:meshHeading | pubmed-meshheading:15521105... | lld:pubmed |
| pubmed-article:15521105 | pubmed:meshHeading | pubmed-meshheading:15521105... | lld:pubmed |
| pubmed-article:15521105 | pubmed:meshHeading | pubmed-meshheading:15521105... | lld:pubmed |
| pubmed-article:15521105 | pubmed:meshHeading | pubmed-meshheading:15521105... | lld:pubmed |
| pubmed-article:15521105 | pubmed:meshHeading | pubmed-meshheading:15521105... | lld:pubmed |
| pubmed-article:15521105 | pubmed:meshHeading | pubmed-meshheading:15521105... | lld:pubmed |
| pubmed-article:15521105 | pubmed:meshHeading | pubmed-meshheading:15521105... | lld:pubmed |
| pubmed-article:15521105 | pubmed:articleTitle | Deletions on chromosome 4 in sporadic and BRCA mutated tumors and association with pathological variables. | lld:pubmed |
| pubmed-article:15521105 | pubmed:affiliation | Department of Pathology, Landspitali-University Hospital by Hringbraut, Reykjavik, Iceland. | lld:pubmed |
| pubmed-article:15521105 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15521105 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15521105 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15521105 | lld:pubmed |
